Julie Maltzman Email

Chief Medical Officer . IconOVir Bio

Current Roles

Employees:
24
Revenue:
$1.9M
About
IconOVir Bio is a preclinical-stage biotechnology company pioneering the next generation of oncolytic virus therapy to improve the treatment of patients with cancer. Our proprietary oncolytic virus platform is based on technology developed by scientific founder Clodagh O'Shea, Ph.D., of the Salk Institute. It is designed to address key limitations of first- and second-generation oncolytic viruses.
IconOVir Bio Address
4570 Executive Drive
San Diego, CA
United States
IconOVir Bio Email

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.